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Purpose: To analyze transforming growth factor beta-induced (TGFBI) gene mutations in a Chinese pedigree with Reis-
Bücklers dystrophy (RBCD).
Methods: In a four-generation Chinese family with Reis-Bücklers dystrophy, six members were patients and the rest were
unaffected. All members of the family underwent complete ophthalmologic examinations. Exons of TGFBI were amplified
by  polymerase  chain  reaction,  sequenced,  and  compared  with  a  reference  database.  The  sequencing  results  were
reconfirmed by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP).
Results: A single heterozygous C>T (R124C) point mutation was found in exon 4 of TGFBI in all six members of the
pedigree affected with RBCD, but not in the unaffected members.
Conclusions: Within this pedigree, RBCD segregates with the R124C variance, which is a known mutation for lattice
corneal dystrophy type I. Therefore, along with G623D and R124L, the R124C mutation in TGFBI is also found to be
responsible for RBCD.
Inherited corneal dystrophy is mainly classified as lattice,
granular, Avellino, Thiel-Behnke, and Reis-Bücklers corneal
dystrophy  (RBCD/CDB1,  OMIM  608470).  RBCD,  a
dominantly inherited dystrophy, is characterized by bilateral,
progressive,  and  painful  corneal  erosions,  and  significant
visual impairment [1]. Histopathologically, the involvement
of the Bowman’s layer, the presence of band-shaped granular
and  subepithelial  deposits  that  stained  intensely  red  with
Masson trichrome, and “rod shaped bodies” in cornea were
confirmed  in  this  disease  [2,3].  The  mechanisms  remain
unclear, but it is generally accepted that transforming growth
factor  beta-induced  (TGFBI)  is  actively  involved  in  the
pathogenesis of RBCD.
Initially  known  as  kerato-epithelin,  TGFBI  is  an
extracellular matrix protein induced by transforming growth
factor-beta 1 and is highly expressed in the corneal epithelium.
It contains a Arg-Gly-Asp (RGD) motif that acts as a ligand
recognition  sequence  for  several  integrins,  and  thus  is
associated with cell-collagen interactions with a role in the
regulation  of  cell-adhesion.  Therefore,  it  is  believed  that
TGFBI plays a role in corneal development and wound healing
by mediating cell adhesion via its interaction with collagen,
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fibronectin, and integrins. The human TGFBI gene encodes a
682  amino  acids  protein  (68  kDa)  with  four  internal
homologous repeats. Currently, more than 30 mutations in
TGFBI have been demonstrated in four different types of
corneal dystrophies [4].
Mutated TGFBI has been linked to the four types of
corneal dystrophy, including RBCD [5-11]. Two mutations,
R124L  [12,13]  and  G623D  [14],  have  previously  been
identified in patients with typical RBCD, including Chinese
RBCD pedigrees. In this study, R124C mutation, rather than
R124L  or  G623D,  was  identified—  to  the  best  of  our
knowledge—for  the  first  time  in  a  Chinese  family  with
RBCD.
METHODS
Patient recruitment: A four-generation Chinese family from
the Sichuan province with RBCD was included in this study
(Figure 1). This study includes six RBCD patients and six
unaffected  relatives.  This  study  was  approved  by  a  local
institutional medical ethics committee, and informed consent
conforming to the tenets of the Declaration of Helsinki was
obtained from each of participants.
Clinical examination: A Snellen best-corrected visual acuity
test, a slit-lamp biomicroscopy, and a fundus examination
were conducted by an experienced ophthalmologist for all
subjects.  Laser  scanning  in  vivo  confocal  microscopy
(Heidelberg Retina Tomograph III, Rostock Corneal Module
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556[RCM];  Heidelberg  Engineering  GmbH,  Heidelberg,
Germany) were also performed on some of the affected and
unaffected individuals.
DNA extraction and polymerase chain reaction: Peripheral
blood samples were drawn from six RBCD patients and six
unaffected members. Leukocyte DNA was extracted from
200 μl peripheral blood using a TIANamp Genomic DNA Kit
(Tiangen  Biotech  Co.  Ltd,  Beijing,  China),  following  the
manufacturer’s instructions. DNA integrity was evaluated by
1% agarose gel electrophoresis. The intronic primers flanking
the  exons  were  designed  based  on  genomic  sequences  of
TGFBI  (Consortium  Human  Build  37  NC_000005)  and
synthesized  by  Invitrogen  Company  (Carlsbad,  CA).  The
sequences of the primers are listed in Table 1.
DNA  fragments  were  amplified  by  PCR  using  a
MyCycler thermocycler (Bio-Rad, Hercules, CA). The 30 μl
PCR reaction mixture included 1× PCR buffer (GC buffer I
were used for several reactions, see Table 1), 30 ng DNA,
2.5 mM MgCl2, 0.3 mM of each of dNTPs, 1.5U Pfu DNA
polymerase, and 1.0 μM of each of the forward and reverse
primers. All reagents used in this procedure were purchased
from TaKaRa Biotechnology Co., Ltd. (Dalian, China). The
reactions were incubated at 94 °C for 3 min, followed by 35
cycles of 94 °C for 10 s, 53–64 °C for 30 s, and 72 ° for 1–2
min, followed by a final extension at 72 °C for 5 min.
Sequencing and PCR-RFLP analysis: The PCR products were
purified  with  a  TIANgel  Midi  Purification  Kit  (Tiangen
Biltech Co. Ltd, Beijing, China) and sequenced using an ABI
377XL  automated  DNA  sequencer  (Applied  Biosystems,
Foster City, CA). Sequence data were compared pair-wise
with the published TGFB1 sequences. To confirm the results
of sequence analysis, a commonly used method of polymerase
chain  reaction-restriction  fragment  length  polymorphism
analysis (PCR-RFLP) [15] was performed, as the pathogenic
mutation (R124C) resulted in a deprivation of a restriction
endonuclease AciI recognition site. Exon 4 of TGFBI was
amplified from each family member by PCR using the primers
mentioned above, purified by a PCR purification kit (Qiagen,
Hamburg, Germany) and digested with an AciI restriction
enzyme (New England Biolabs, Inc., Beverly, MA) for 3 h at
37 °C. Fragments were analyzed by electrophoresis.
RESULTS
Clinical  presentation:  In  the  family,  six  individuals  with
RBCD and six unaffected individuals were examined. The
proband  (a  33-year-old  male,  patient  III:3,  Figure  1)
experienced recurrent photophobia, progressive vision loss,
and corneal erosion since the age of 10. At the time of the
examination, the best corrected visual acuity was hand motion
(OD) and 6/600 (OS). Slit lamp examination showed multiple
annular  grayish  opacities  at  the  subepithelial  and  anterior
stroma of the central cornea of both eyes. Representative
clinical  photographs  of  the  cornea  of  an  affected  family
member are shown in Figure 2. Patient IV:3, the 4-year-old
son of the proband, presented with no clinical symptoms, but
manifested  bilateral  diffuse  and  small  dot  epithelial  and
subepithelial opacities in the central cornea (Figure 2).
In  vivo  laser  scanning  confocal  microscopy  was
performed on the proband. Focal depositions of homogeneous
reflective materials with rounded and hyporeflective edges
were observed (Figure 3).
TGFBI  mutation  analysis:  A  single  heterozygous  C>T
mutation  was  found  (R124C)  in  exon  4  of  TGFBI  in  all
affected members of this pedigree (Figure 4). This R124C
mutation co-segregated with the disorder within the family.
This mutation causes an Arginine to Cysteine substitution at
the protein level. The results of the sequencing analysis were
confirmed by PCR-RFLP analysis (Figure 5). After digestion,
wild type alleles were cut into two fragments, 181 bp and 172
bp, whereas the affected patients’ alleles were cut into three
fragments, 353 bp, 181 bp, and 172 bp.
DISCUSSION
Corneal  dystrophy  is  a  group  of  diseases  with  autosomal
dominant inheritance. Until now, corneal dystrophies failed
Figure 1. The pedigree of the family with Reis-Bücklers dystrophy (RBCD). The circle indicates female, the square indicates male, and the
filled circle or square indicates the affected individual with RBCD. Arrow signifies the proband and slash through symbol indicates death.
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557to be clearly classified because of the variability in phenotypic
expression of the diseases. A proposed corneal dystrophy
classification system, which is identical or similar to those in
the  current  nomenclature,  is  anatomically  based  with
dystrophies classified according to the layer mainly involved,
such  as  the  epithelial  and  subepithelial,  Bowman’s  layer,
stroma,  Descemet’s  membrane,  and  endothelium  [16].
Clinical  characteristics  such  as  the  depth  of  the  cornea
affected,  the  morphology  of  the  deposits,  and  the
histopathological features are also important for classifying
different corneal dystrophies [17]. However, dystrophies with
overlapping and atypical characteristics are still too similar to
be distinguished from one another. A Chinese family with
atypical  RBCD  was  recently  reported  [14].  This  family
presented  with  a  unique  corneal  dystrophy  within  the
Bowman’s layer and the corneal stroma. However, no lattice
was noted in the proband or other affected members, and the
deposits were located in the mid-stroma of the cornea, which
was  different  from  the  phenotypes  previously  reported  in
lattice corneal dystrophy patients with R124C mutation. Some
corneal  dystrophies  affect  multiple  corneal  layers  and
therefore  cannot  be  classified  as  a  single  type  based  on
morphologic criteria.
Phenotypically,  the  pedigree  we  documented  here
exhibited typical features of RBCD. The affected individuals
presented with a gray-white geographic opacity in the anterior
to mid-stroma of both eyes. In addition, geometric and round
opacities in the subepithelial layers and anterior to mid-stroma
were found in all of the affected family members. The clinical
features,  including  recurrent  erosion  and  gradually






1 Forward: GCTTGCCCGTCGGTCGCTA 62
  Reverse: TCCGAGCCCCGACTACCTGA  
2 Forward: AGGCAAACACGATGGGAGTCA 60
  Reverse: TAGCACGCAGGTCCCAGACA  
3 Forward: CCAGATGACCTGTGAGGAACAGTGA 60
  Reverse: CCTTTTATGTGGGTACTCCTCTCT  
4 Forward: TCCTCGTCCTCTCCACCTGT 58
  Reverse: CTCCCATTCATCATGCCCAC  
5 and 6 Forward: CCTGGGCTCACGAGGGCTGAGAACAT 64
  Reverse: GCCCCTCTTGGGAGGCAATGTGTCCC  
7 Forward: GTGAGCTTGGGTTTGGCTTC 63
  Reverse: ACCTCATGGCAGGTGGTATG  
8 Forward: TGAGGTTATCGTGGAGTG 53
  Reverse: CACATCAGTCTGGTCACA  
9 Forward: ACTCACGAGATGACATTCCT 60
  Reverse: TCCAGGGACAATCTAACAGG  
10 Forward: TAGAAGATACCAGATGTTAAGG 56
  Reverse: TGTCAGCAACCAGTTCTCAT  
11 Forward: CCTGCTACATGCTCTGAACAA 58
  Reverse: GAATCCCCAAGGTAGAAGAAAG  
12 Forward: GACTCTACTATCCTCAGTGGTG 58
  Reverse: ATGTGCCAACTGTTTGCTGCT  
13 Forward: CATTAGACAGATTGTGGGTCA 60
  Reverse: GGGCTGCAACTTGAAGGTT  
14 Forward: GCGACAAGATTGAAACTCCAT 58
  Reverse: CTCTCCACCAACTGCCACAT  
15 Forward: CCCTCAGTCACGGTTGTT 58
  Reverse: GGAGTTGCCTTGGTTCTT  
16 Forward: CTTGCACAACTTATGTCTGC 58
  Reverse: TGCACCATGATGTTCTTATC  
17 Forward: AGTGAAGTTTCACAAACCAC 58
  Reverse: CCACATTTGGGATAGGTC  
Summary of the primers and annealing temperatures used for the amplification of the 17 exons of  TGFBI .
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558developing opacities of the Bowman’s layer, were consistent
with the characteristic of RBCD [1,18] and to those found in
the families previously described by Afshari et al. [10] and
Aldave et al. [19]. In vivo confocal microscopy images were
also consistent with the reported findings in RBCD [20].
TGFBI  has  been  closely  involved  with  the  inherited
corneal dystrophies, as mutations in this gene were identified
in at least 5 types of corneal dystrophies, including granular
corneal  dystrophy  (R555W),  Avellino  corneal  dystrophy
(R124H), lattice corneal dystrophy type I (R124C), Thiel-
Behnke  corneal  dystrophy  (R555L),  and  RBCD  (R124L,
G623D)  [10,19].  Among  those  mutations  reported,  R124
appeared to be a “hot-spot” point mutation in TGFBI [21,22]
as the R124 mutation has been detected in three types of
corneal dystrophies, including Avellino corneal dystrophy,
lattice  corneal  dystrophy  type  I,  and  RBCD.  In  previous
Figure 2. Slit-lamp examination showed an irregular corneal surface and several discrete, gray-white opacities in the subepithelial area and
Bowman’s layer. Some of the opacities were associated with marked corneal scarring. No neovascularization and stromal lattice were observed.
Figure 3. In vivo laser scanning confocal microscopy. A–D: Patient III:3 36 μm (A), 42 μm (B), 59 μm (C), and 110 μm (D) from the corneal
surface. Focal deposition of homogeneous reflective materials with rounded and hyporeflective edges were observed (A–C). Amyloid-like
deposits that were hyperreflective and with poorly demarcated margins were observed (D). E–H: Normal individual: 36 μm (A), 42 μm (B),
57 μm (C), and 113 μm (D) from the corneal surface. Epithelium cells (E, F) nerve fibers (G), and corneal stromal cells (H) were observed.
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559reports, R124C is associated with lattice corneal dystrophy
[15,21,23].  Interestingly,  R124  in  exon  4  of  TGFBI  is
conserved among several species, including Homo sapiens,
Mus  musculus  (R124),  Pan  troglodytes  (R124),  Macaca
mulatta  (R124),  and  Rattus  norvegicus  (R124),  and  is
incompletely conserved in Gallus gallus (R117) and Danio
rerio  (R118).  It  strongly  suggests  that  this  residue  is  an
important—functional and structural—site of the protein.
To date, TGFBI was the only gene found to be associated
with  RBCD.  Here,  we  demonstrated  an  unusual  R124C
mutation in TGFBI associated with the RBCD, which was a
mutation  known  to  be  responsible  for  corneal  lattice
dystrophy type I. Therefore, along with G623D and R124L,
the R124C mutation in TGFBI is also found to be responsible
for RBCD.
In 1996, Small et al. [24] suggested that Reis-Bücklers,
lattice type 1, Avillino, and granular corneal dystrophies are
all the same disease as they stem from the same gene products.
Recently, it was suggested by the International Committee for
Classification  of  Corneal  Dystrophy  that  the  following
corneal dystrophies be named as TGFBI corneal dystrophies,
including granular corneal dystrophy type 3 (RBCD), Thiel–
Behnke corneal dystrophy (TBCD), classic lattice corneal
dystrophy  (LCD1),  Granular  corneal  dystrophy,  type  1
(classic;  GCD1),  and  Granular  corneal  dystrophy,  type  2
(granular-lattice; GCD2) [16]. Corneal dystrophies caused by
mutations  in  TGFBI  are  characterized  by  abnormal
extracellular deposits of mutated TGFBI protein in the corneal
stroma. Most of TGFBI mutations so far reported are located
in the fourth Fas1 domain with two mutational hot spots in
R124  and  R555.  There  is  a  strong  correlation  between
phenotype-genotype in most corneal dystrophies caused by
TGFBI  mutations.  The  corneal  dystrophy  with  R124L
mutation usually has a worse prognosis, whereas the clinical
manifestations of corneal dystrophies resulting from R555T
or R555C mutations are usually mild. Other mutations such
as P501T and N622K are related to various subtypes of lattice-
like  dystrophies.  However,  as  dystrophies  have  a  known
common genetic basis, they may be classified into a single
category, TGFBI dystrophy [16].
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